Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011 - Wikidata - awgldk - TriplyDB

Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011

Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011

http://www.wikidata.org/entity/Q34643685

about

A Guide to Improving the Care of Patients with Fragility Fractures, Edition 2 Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial International Geriatric Fracture Society CORE Certification: Turning Knowledge into Action Soluble guanylate cyclase as a novel treatment target for osteoporosis.Romosozumab for the treatment of osteoporosis.Osteoporosis diagnosis in men: the T-score controversy revisited.Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study Odanacatib: a review of its potential in the management of osteoporosis in postmenopausal women Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010 Management of severe osteoporosis.Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients' and Practitioners' Views.Managing Osteoporosis: A Survey of Knowledge, Attitudes and Practices among Primary Care Physicians in Israel.Can orthopedic surgeons help create a better head start for osteoporosis treatment after hip fracture?Fracture liaison services: improving outcomes for patients with osteoporosis.Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.Reprint of: The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide.The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide.The Ability of a Single BMD and Fracture History Assessment to Predict Fracture Over 25 Years in Postmenopausal Women: The Study of Osteoporotic Fractures.Osteoporosis in Crisis: It's Time to Focus on Fracture.A Survey of Women's Awareness of and Reasons for Lack of Postfracture Osteoporotic Care.Osteoporosis-Related Health Services Utilization Following First Hip Fracture Among a Cohort of Privately-Insured Women in the United States, 2008-2014: An Observational Study.Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis.A pilot randomized controlled trial of a decision aid with tailored fracture risk tool delivered via a patient portal.Trends in osteoporosis and low bone mass in older US adults, 2005-2006 through 2013-2014.Spine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014.Disparities in osteoporosis treatments.Review: Breaking From Bisphosphonates.Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward.Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial.Compliance to The Joint Commission proposed Core Measure set on osteoporosis-associated fracture: review of different secondary fracture prevention programs in an open medical system from 2010 to 2015.Utilization and cost of anti-osteoporosis therapy among US Medicare beneficiaries.Telementoring: a novel approach to reducing the osteoporosis treatment gap.Impact of the U.S. Food and Drug Administration's Safety-Related Announcements on the Use of Bisphosphonates After Hip Fracture Results of a fracture liaison service on hip fracture patients in an open healthcare system.Patient and Provider Characteristics Associated With Optimal Post-Fracture Osteoporosis Management.Activating Patients With a Tailored Bone Density Test Results Letter and Educational Brochure: the PAADRN Randomized Controlled Trial.Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996-2012.Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study.Bisphosphonate drug holidays: we reap what we sow.

P2860

Q28647551-81A2F872-EFA8-48EC-9558-9002DAB046A0 Q30234621-5D54D7E3-9655-4BA2-B73D-7D600B49F25B Q34375420-A3D4972D-D416-447D-ACC2-9B810250F446 Q34418587-CBA3C0CA-5563-4B58-8700-715D8F2FD112 Q34551704-F267318A-1213-4231-ADBB-5E744BDB7A1D Q34680463-955A0531-2B76-45C1-BD49-6963472386FE Q34763893-FBEC70F9-BD0B-4888-AA6C-72CA07C688F7 Q35554696-AA2AE994-534C-4B1D-8164-3CD7EB8A3316 Q35589110-A55CF966-6BA0-4C65-B483-DB7CF50E4B9E Q35789242-1AEE5403-C16F-44A3-BBF0-5016C808EE1C Q35852252-FFEE2668-57D8-457D-B5AC-C65318625E67 Q36063957-14DDDC54-2CE3-4EF9-8E74-01D8914BF256 Q36095900-462FD452-52BB-4987-AE96-C2AC3D70AA7D Q37328153-401F2F7B-513F-426D-A0C2-10B5500AFB25 Q37587203-B3F87F21-DE5D-488D-B036-FCE9E16FB897 Q37596145-CA184974-2530-42AC-8FA4-885A89BD8F8A Q38402233-F84EAF1D-A790-41B9-94EC-7025502C5FFA Q38406462-0D6AF6D3-DA77-4766-BDEC-AA6399975496 Q38673726-ACE7B00E-8548-43D8-9A33-D51D409580CD Q38677489-A08EA7D6-A837-4D05-BA2D-5C38EC2F07EB Q38728444-61062778-1C7A-41AF-9B88-921FC0AF6497 Q38754305-76F239CD-1616-40BC-B70B-04624F81751D Q38806177-2DA96948-7E9B-41B4-AB9B-81073B4D01D9 Q38819578-467D8900-F1FC-483E-AC8D-F79E0CE9176D Q38896151-6D6506B4-27D8-418F-8603-CF981F36E013 Q38973074-11EE7A59-CAF7-4EAB-A78A-2FF1E064D0DA Q38980554-22F71427-71C9-43B1-9E57-1252F0363172 Q38992765-C2C0DFA2-310A-490E-9049-F60E84B6A263 Q39014377-138BE3CC-B63E-4E4A-AF92-B9B724FE094B Q39064322-F7E9918E-A462-4D36-99E6-C657A7EA2475 Q39117115-2B71E6C7-CF27-4F68-B8AD-83DC5D2477F4 Q39439437-1F601879-2550-4217-B4AC-DE8F5A3F906A Q39579615-D508A267-B045-4AA7-9FC6-787C32F495F8 Q39926515-387AA9D6-8284-4EF6-88B2-9498FC4CEEC6 Q39980203-84512709-8005-4C96-85BF-89925DBF5E2B Q40485085-5925585A-7287-44B4-8C02-992B15C8D622 Q40574269-2AE57BF3-8A8D-487D-984C-562E091D9317 Q40772668-5444B9E3-D56A-46BC-A160-904E2ACBE03E Q41717921-2FD9B38E-6AC2-442B-A836-C60CDD9F38F8 Q46648831-0AFE55E4-FD1F-4C12-B3C8-8B0E96F862F0

P2860

Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011

http://www.wikidata.org/entity/Q34643685

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011

@ast

Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011

@en

Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011

@nl

type

label

Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011

@ast

Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011

@en

Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011

@nl

prefLabel

Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011

@ast

Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011

@en

Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011

@nl

P1433

Q34643685-AA02F56F-9214-41F6-AE00-9F123C6F4E32

P1476

Q34643685-F5DBBD18-652F-4A50-9E47-DF34B35DEA62

P2093

Q34643685-4B7FAE5E-E79E-4CF7-95F6-B0D97E8118B7

Q34643685-BA00EB5A-FC82-4D09-ABE8-259699A28477

Q34643685-BB3F5071-8783-4CEB-9206-63D139DB9578

Q34643685-D579C720-CA82-4423-8A42-CB97E36ACDDA

Q34643685-E04EE79C-E619-435B-B939-41BCDF36D4C3

P2860

Q34643685-17D46D36-42DC-4773-8010-E7C0E37EEE72

Q34643685-1A2F9BD4-103D-4729-AC0F-35A7A410771C

Q34643685-1F2DD226-90F1-4EC4-9616-7FA26C7F07C7

Q34643685-39D48119-18CE-4EFD-8227-BB5D03DC90FD

Q34643685-41DCAC39-507C-45FB-884D-527CAF306EEC

Q34643685-66E1B8B2-D7E4-452C-944A-9E5DE05968F6

Q34643685-682B376E-E1C0-4CB4-B498-3F1E23CEBAB2

Q34643685-75E67681-3D32-4E16-8098-B51E27EFB35D

Q34643685-80EC13FF-5786-4DC9-98AA-A18E7F6B9973

Q34643685-8271184F-E758-472D-A815-5FA141EFB69E

P304

Q34643685-50B16A53-87E6-46E2-9C0A-26D6EF34F8D4

P31

Q34643685-4CA46525-0BB0-4285-AEB4-02D66CBA4E89

P356

Q34643685-DE84E031-B089-4607-BB74-A6998ACF726D

P433

Q34643685-5A1E71B2-15AD-430C-9B13-1E698DC8B80C

P478

Q34643685-8564656F-2240-4A51-8CB6-DE8B10010256

P50

Q34643685-2A0B8122-DB55-4AA3-A73B-637EBF566FD7

P577

Q34643685-AD814EB9-1EED-4915-8953-3E4F5690EF0B

P5875

Q34643685-9923DD08-10FA-4D07-B574-FA08F9843509

P698

Q34643685-FE01EE20-BC55-41B5-8F07-AC404E3D0781

P921

Q34643685-17FB4AA4-01C4-4C7D-BF5C-A55D98D47040

Q34643685-986A7496-7FB3-4241-B23B-9CFA524DBCB8

P932

Q34643685-3E7675C4-AE88-4D74-91E0-E49F5BCA2F96

P356

P1433

Journal of Bone and Mineral Research

P1476

Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011

@en

P2093

Daniel H Solomon

http://www.w3.org/2001/XMLSchema#string

Donna McMorrow

http://www.w3.org/2001/XMLSchema#string

Joseph M Lane

http://www.w3.org/2001/XMLSchema#string

Kelly D Krohn

http://www.w3.org/2001/XMLSchema#string

Stephen S Johnston

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Safety issues with bisphosphonate therapy for osteoporosis

Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture.

Improving osteoporosis assessment in the fracture clinic.

Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004.

Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs.

Public health impact of osteoporosis.

Mortality following hip fracture: trends and geographical variations over the last 40 years.

Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA results

Quality of life related to fear of falling and hip fracture in older women: a time trade off study.

P304

1929-1937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBMR.2202

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Natalie Boytsov

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260241871

http://www.w3.org/2001/XMLSchema#string

P698

24535775

http://www.w3.org/2001/XMLSchema#string

P921

P932

4258070

http://www.w3.org/2001/XMLSchema#string